Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score?

Hugo J A Adams; Thomas C. Kwee

doi:10.1111/bjh.14052

Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score?

Hugo J A Adams
, Thomas C. Kwee

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	319-320
Number of pages	2
Journal	British Journal of Haematology
Volume	177
Issue number	2
DOIs	https://doi.org/10.1111/bjh.14052
Publication status	Published - 1 Apr 2017

Keywords

diffuse large B-cell lymphoma
fluorodeoxyglucose-positron emission tomography
International Harmonization Project
National Comprehensive Cancer Network International Prognostic Index
response assessment

Access to Document

10.1111/bjh.14052

DoesFinal published version, 59.2 KBLicence: Taverne

Cite this

@article{7ffd776e620845688087533d04ac03ce,

title = "Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score?",

keywords = "diffuse large B-cell lymphoma, fluorodeoxyglucose-positron emission tomography, International Harmonization Project, National Comprehensive Cancer Network International Prognostic Index, response assessment",

author = "Adams, \{Hugo J A\} and Kwee, \{Thomas C.\}",

year = "2017",

month = apr,

day = "1",

doi = "10.1111/bjh.14052",

language = "English",

volume = "177",

pages = "319--320",

journal = "British Journal of Haematology",

issn = "0007-1048",